Equine N-MID OC antibody and antigen (recombinant protein)

Diagnostic anti-Equine N-MID OC antibodies pairs and antigen for animal health (animal Equine/Horse osteoporosis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-EQU-N-MID-OC-Ag01 Recombinant Equine N-MID OC protein 3090
GMP-EQU-N-MID-OC-Ab01 Anti-Equine N-MID OC mouse monoclonal antibody (mAb) 1953
GMP-EQU-N-MID-OC-Ab02 Anti-Equine N-MID OC mouse monoclonal antibody (mAb) 1953
GMP-EQU-N-MID-OC-Ab03 Anti-Equine N-MID OC human monoclonal antibody (mAb) 1953
GMP-EQU-N-MID-OC-Ab04 Anti-Equine N-MID OC human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-EQU-N-MID-OC-Ag01
Product Name Recombinant Equine N-MID OC protein
Target/Biomarker Equine N-terminal midfragment of Osteocalcin (N-MID OC)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Equine N-terminal midfragment of Osteocalcin antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in N-MID OC level test of animal Equine/Horse with osteoporosis.
Tag His
Products description Recombinant Equine N-MID OC protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-N-MID-OC-Ab01, GMP-EQU-N-MID-OC-Ab02
Product Name Anti-Equine N-MID OC mouse monoclonal antibody (mAb)
Target/Biomarker Equine N-terminal midfragment of Osteocalcin (N-MID OC)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Equine N-terminal midfragment of Osteocalcin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies in N-MID OC level test of animal Equine/Horse with osteoporosis.
Tag mFc
Products description Anti-Equine N-MID OC mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-N-MID-OC-Ab03, GMP-EQU-N-MID-OC-Ab04
Product Name Anti-Equine N-MID OC human monoclonal antibody (mAb)
Target/Biomarker Equine N-terminal midfragment of Osteocalcin (N-MID OC)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Equine N-terminal midfragment of Osteocalcin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies in N-MID OC level test of animal Equine/Horse with osteoporosis.
Tag hFc
Products description Anti-Equine N-MID OC human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-N-MID OC antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Equine N-MID Osteocalcin (Equine N-MID OC) stands as a cornerstone of equine bone health. Within the vast and powerful physique of the horse, this biomarker plays an indispensable role in ensuring the structural integrity of the skeletal system. It is a fragment of the larger osteocalcin molecule, residing within the Equus ferus caballus species. At its core, Equine N-MID OC is a regulator of bone mineralization and turnover. Its presence and activity are pivotal in orchestrating the formation of hydroxyapatite crystals, the mineral matrix that fortifies equine bones. This mineralization process is fundamental to sustaining the strength and durability required for horses to gallop, jump, and carry out their remarkable feats. Osteocalcin itself is synthesized predominantly by osteoblasts, the dedicated bone-forming cells within the equine body. Equine N-MID OC, arising from the central region of the osteocalcin molecule, represents a nexus of control in the intricate web of bone metabolism.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment